{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T12:29:56Z","timestamp":1791030596556,"version":"4.1.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:00:00Z","timestamp":1694563200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>To evaluate the effectiveness and potential mechanism of traditional Chinese medicine Jiawei-Xiaoyao-San (JWXYS) as an adjunct or mono- therapy for antithyroid drugs (ATDs) in the treatment of hyperthyroidism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eight databases and three trial registries were searched from inception until May 2023. Randomized controlled trials (RCTs) were included and meta-analysis was conducted using RevMan 5.4 and Stata 14.0. The Cochrane risk of bias (ROB) tool 1.0 and GRADE tool was used for quality appraisal. The findings from case reports using mono-JWXYS and pharmacological studies were summarized in tables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirteen RCTs with 979 participants were included. The majority of the included studies were assessed as high risk of bias in one ROB domain. Compared with ATDs, JWXYS plus ATDs resulted in lower free triiodothyronine (FT3) (MD = -1.31 pmol\/L, 95% CI [-1.85, -0.76]; low-certainty), lower free thyroxine (MD = -3.24 pmol\/L, 95% CI [-5.06, -1.42]; low-certainty), higher thyroid stimulating hormone (MD = 0.42 mIU\/L, 95% CI [0.26, 0.59]; low-certainty), higher effectiveness rate of traditional Chinese medicine syndrome (RR = 1.28, 95% CI [1.08, 1.52]; low-certainty), lower goiter score (MD = -0.66, 95% CI [-1.04, -0.29]; very low-certainty), lower thyrotrophin receptor antibody (SMD = -0.44, 95% CI [-0.73, -0.16]; low-certainty) and fewer adverse events (AEs) (RR = 0.34, 95% CI [0.18, 0.67]; moderate-certainty). Compared with regular dosage of ATDs, JWXYS plus half-dose ATDs resulted in fewer AEs (RR = 0.24, 95% CI [0.10, 0.59]; low-certainty). Compared with ATDs in 1 trial, JWXYS resulted in higher FT3, lower goiter score and fewer AEs. Three case reports showed that the reasons patients sought TCM-only treatment include severe AEs and multiple relapses. Three pharmacological studies demonstrated that JWXYS restored Th17\/Treg balance, lowered deiodinases activity, regulated thyroid cell proliferation and apoptosis, and alleviated liver oxidative stress in mouse or rat models.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>JWXYS may enhance the effectiveness of ATDs for hyperthyroidism, particularly in relieving symptoms and reducing AEs. Mono-JWXYS is not recommended except in patients intolerant to ATDs. The findings should be interpreted with caution due to overall high risk of bias. Further pharmacological studies with more reliable models are needed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/prospero\/<\/jats:uri>, identifier CRD42023394923.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1241962","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:54:44Z","timestamp":1694642084000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Effectiveness and potential mechanism of Jiawei-Xiaoyao-San for hyperthyroidism: a systematic review"],"prefix":"10.3389","volume":"14","author":[{"given":"Wenxin","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruotong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longkun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyue","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"Itc49","DOI":"10.7326\/aitc202004070","article-title":"Hyperthyroidism","volume":"172","author":"McDermott","year":"2020","journal-title":"Ann Internal Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet (London England)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1159\/000356954","article-title":"Effect of hyperthyroidism on the hypercoagulable state and thromboembolic events in patients with atrial fibrillation","volume":"127","author":"Chen","year":"2014","journal-title":"Cardiology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-4184","article-title":"Subclinical and overt thyroid dysfunction and risk of all-cause mortality and cardiovascular events: A large population study","volume":"99","author":"Selmer","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.285606","article-title":"Variation in rates of autoimmune thyroid disease by race\/ethnicity in us military personnel","volume":"311","author":"McLeod","year":"2014","journal-title":"Jama"},{"key":"B7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3803\/EnM.2019.34.1.29","article-title":"Graves' Disease: can it be cured","volume":"34","author":"Wiersinga","year":"2019","journal-title":"Endocrinol Metab (Seoul Korea)"},{"key":"B8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41572-020-0184-y","article-title":"Graves' Disease","volume":"6","author":"Davies","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0044","article-title":"Quality-of-life impairments persist six months after treatment of graves' Hyperthyroidism and toxic nodular goiter: A prospective cohort study","volume":"26","author":"Cramon","year":"2016","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/eje-19-0587","article-title":"Impact of total thyroidectomy on quality of life at 6 months: the prospective thyrqol multicentre trial","volume":"182","author":"Miralli\u00e9","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0315","article-title":"Impaired quality of life after radioiodine therapy compared to antithyroid drugs or surgical treatment for graves' Hyperthyroidism: A long-term follow-up with the thyroid-related patient-reported outcome questionnaire and 36-item short form health status survey","volume":"29","author":"T\u00f6rring","year":"2019","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2019.0132","article-title":"Patterns of use, efficacy, and safety of treatment options for patients with graves' Disease: A nationwide population-based study","volume":"30","author":"Brito","year":"2020","journal-title":"Thyroid: Off J Am Thyroid Assoc"},{"key":"B13","doi-asserted-by":"publisher","first-page":"Cd010094","DOI":"10.1002\/14651858.CD010094.pub2","article-title":"Radioiodine therapy versus antithyroid medications for graves' Disease","volume":"2","author":"Ma","year":"2016","journal-title":"Cochrane Database systematic Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01730-1","article-title":"Appropriate duration of antithyroid drug treatment as a predictor for relapse of graves' Disease: A systematic scoping review","volume":"45","author":"Azizi","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1530\/eje-18-0678","article-title":"Anniversary review: antithyroid drug therapy: 70 years later","volume":"179","author":"Burch","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.explore.2020.10.007","article-title":"Successful intervention with chinese herbal medicine for hyperthyroidism: two case reports and a literature review","volume":"17","author":"Lin","year":"2021","journal-title":"Explore (New York NY)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctim.2018.05.015","article-title":"A methimazole resistant patient with graves' Disease (Gd): A case report of mid-term management with herbal decoctions mainly composed of anemarrhena bunge","volume":"39","author":"Kim","year":"2018","journal-title":"Complement Ther Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.jsps.2020.12.004","article-title":"Ethnopharmacological study of herbal remedies used for the management of thyroid disorders in Algeria","volume":"29","author":"Ta\u00efbi","year":"2021","journal-title":"Saudi Pharm journal: SPJ Off Publ Saudi Pharm Soc"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.862831","article-title":"New therapeutic horizon of graves' Hyperthyroidism: treatment regimens based on immunology and ingredients from traditional chinese medicine","volume":"13","author":"He","year":"2022","journal-title":"Front Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5500604","article-title":"The utilization of chinese herbal products for hyperthyroidism in national health insurance system (Nhird) of Taiwan: A population-based study","volume":"2022","author":"Chang","year":"2022","journal-title":"Evidence-Based Complementary Altern Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1002-2619.2013.02.011","article-title":"Clinical study of danzhi xiaoyao pill in treating hyperthyroidism induced liver injury [Article in chinese]","volume":"35","author":"Huang","year":"2013","journal-title":"Hebei Traditional Chin Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.16448\/j.cjtcm.2021.0434","article-title":"Clinical observation of danzhi xiaoyao powder in the treatment of irate exuberant syndrome of graves disease","volume":"33","author":"Gao","year":"2021","journal-title":"Clin J Traditional Chin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2010.0114","article-title":"Is traditional chinese medicine effective for reducing hyperthyroidism","volume":"16","author":"Chang","year":"2010","journal-title":"J Altern complementary Med (New York NY)"},{"key":"B24","first-page":"95","article-title":"Using danzhi xiaoyao powder to treat hyperthyroidism","volume":"27","author":"Xia","year":"2009","journal-title":"Sichuan Traditional Chin Med"},{"key":"B25","volume-title":"Cochrane handbook for systematic reviews of interventions version 6.3","author":"Higgins JPT","year":"2022"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B27","article-title":"Guiding principle of clinical research on new drugs of traditional chinese medicine","volume":"229","author":"Zheng","year":"2002"},{"key":"B28","first-page":"3","article-title":"Joanna briggs institute reviewers\u2019 Manual","volume-title":"The joanna briggs institute","author":"Institute","year":"2016"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/jrsm.1429","article-title":"Optimally estimating the sample standard deviation from the five-number summary","volume":"11","author":"Shi","year":"2020","journal-title":"Res synthesis Methods"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ (Clinical Res ed)"},{"key":"B31","volume-title":"Clinical observation on the treatment of blood glucose, blood lipid and depression in patients with hyperthyroidism (Type of pathogenic fire derived from stagnation of liver-qi) by soothing the liver and puring fire","author":"Liu","year":"2012"},{"key":"B32","volume-title":"Liver hydrophobic heat method integrated clinical intervention for patients with hyperthyroidism","author":"Zhang","year":"2017"},{"key":"B33","article-title":"Clinical study on danzhi compound in treating hyperthyroidism (Type of liver depression inducing fire)","volume":"34","author":"Fu","year":"2016","journal-title":"J Sichuan Traditional Chin Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.16808\/j.cnki.issn1003-7705.2020.11.023","article-title":"Clinical trial of danzhixiaoyao powder combined with thiamazole in treating hyperthyroidism [Article in chinese]","volume":"36","author":"Tian","year":"2020","journal-title":"Hunan J Traditional Chin Med"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.3760\/cma.j.issn.1674-4756.2015.06.058","article-title":"Clinical study of danzhi xiaoyao powder combined with methimazole in treating hyperthyroidism","volume":"41","author":"Shi","year":"2020","journal-title":"Shanxi J Traditional Chin Med"},{"key":"B36","volume-title":"Clinical study on the treatment of hyperthyroidism (Liver-fire exuberance syndrome) by inhibiting yang and strengthening yin","author":"Li","year":"2018"},{"key":"B37","volume-title":"Clinical observation on effect of danzhixiaoyao powder in the treatment of hyperthyroidism","author":"Wu","year":"2017"},{"key":"B38","volume-title":"Effects of danzhi compound on the thyroid function in mice with graves\u2019 Hyperthyroidism and patients with hyperthyroidism characterized with pathogentic fire derived from stagnation of liver-qi","author":"Li","year":"2016"},{"key":"B39","volume-title":"Clinical curative effect observation of danzhixiaoyaosan on treating hyperthyroidism (the type of heart-fire and liver-fire)","author":"Li","year":"2016"},{"key":"B40","article-title":"Clinical observation of xiaoyao powder combined with western medicine in treating hyperthyroid cardiopathy","volume":"24","author":"Qiu","year":"2015","journal-title":"J Emergency Traditional Chin Med"},{"key":"B41","volume-title":"Clinical observation of the treatment of graves' Disease by using dan zhi xiaoyao powder","author":"Guo","year":"2015"},{"key":"B42","volume-title":"Clinical observation on the method of soothing liver and clearing heat in the treatment of patients with hyperthyroidism (Type of liver depression inducing fire)","author":"Zhang","year":"2012"},{"key":"B43","volume-title":"Clinical research of danzhi xiaoyao powder modified thismazole on hyperthyroidism","author":"Wang","year":"2011"},{"key":"B44","volume-title":"Clinical observation of the effect of dan zhi xiao yao decoction on the patients with liver stagnation and spleen deficiency and heat of hashimoto's thyroiditis and hyperthyroidism","author":"Tang","year":"2012"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.13359\/j.cnki.gzxbtcm.2019.07.026","article-title":"Effects of propyl thiouracil combined with danzhi compound on thyroid function in the progeny of mice with hyperthyroidism and pregnancy","volume":"36","author":"Bao","year":"2019","journal-title":"J Guangzhou Univ Chin Med"},{"key":"B46","volume-title":"Study on dose-effect and time-effect relationship and mechanism of danzhi compound in treating graves disease mice in the view of \"Liver\"","author":"Tan","year":"2017"},{"key":"B47","volume-title":"Effect of danzhi compound on oxidative stress response of liver injury in hyperthyroidism model mice","author":"Liu","year":"2017"},{"key":"B48","volume-title":"Effects of danzhi compound on thyroid function, liver injury and oxidative stress in gd mice","author":"Liu","year":"2017"},{"key":"B49","volume-title":"Preliminary study on the efficacy and pharmacology of jiawei xiaoyao pills in treating graves' Disease","author":"Wu","year":"2021"},{"key":"B50","volume-title":"Effect of danzhi compound on the expression of thyroid caspase-3, bcl-2 and bax protein in mice with graves' Disease","author":"Huang","year":"2017"},{"key":"B51","volume-title":"Effects of danzhi compound on thyroid function and DNA oxidative damage of hepatocytes in hyperthyroidism model mice","author":"Jia","year":"2017"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.16025\/j.1674-1307.2020.07.022","article-title":"Clinical observation on hypothyroidism of hashimoto's thyroiditis treated with xiakucao granules and danzhi xiaoyao san granules together","volume":"39","author":"Du","year":"2020","journal-title":"Beijing J Traditional Chin Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-7369.2015.09.038","article-title":"Observation on the curative effect of jiawei xiaoyao san combined with indomethacin in the treatment of subacute thyroiditis","volume":"36","author":"Cui","year":"2015","journal-title":"Shaanxi J Traditional Chin Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.14163\/j.cnki.11-5547\/r.2020.11.001","article-title":"Effect of danzhi-xiaoyao san on tear th1\/th2 cytokines levels in patients with active thyroid-associated ophthalmopathy","volume":"15","author":"Fan","year":"2020","journal-title":"Chin Pract Med"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.13359\/j.cnki.gzxbtcm.2016.06.013","article-title":"Clinical effect of modified dan zhi xiaoyao powder combined with xiaojin pills for treatment of nodular goiter","volume":"33","author":"Gao","year":"2016","journal-title":"J Guangzhou Univ Traditional Chin Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115045","article-title":"Xiao-luo-wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the pi3k-akt\/ras pathways based on uplc\/ms and network pharmacology","volume":"289","author":"Dong","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.chmed.2021.12.005","article-title":"Emerging therapeutic role of prunella vulgaris in thyroid disease","volume":"14","author":"Zhang","year":"2022","journal-title":"Chin Herbal Med"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.13193\/j.issn.1673-7717.2022.05.050","article-title":"Effect of danzhi xiaoyao powder in treatment of graves disease in women of childbearing age","volume":"40","author":"Liu","year":"2022","journal-title":"Chin Arch Traditional Chin Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2021.22.009","article-title":"Clinical study on modified danzhi xiaoyao powder combined with propylthiouracil for gestational hyperthyroidism of intense liver fire type","volume":"53","author":"Liu HJ","year":"2021","journal-title":"New Chin Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.13457\/j.cnki.jncm.2016.12.023","article-title":"Observation of curative effect of danzhi xiaoyao powder combined with western medicine in the treatment of hyperthyroidism and its influence on hemodynamics","volume":"48","author":"Pan","year":"2016","journal-title":"New Chin Med"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0148","article-title":"An improved mouse model of graves disease by once immunization with ad-tshr289","volume":"66","author":"Tang","year":"2019","journal-title":"Endocr J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2020.101414","article-title":"Management of thyrotoxicosis during pregnancy","volume":"34","author":"Andersen","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c332","article-title":"Consort 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1241962\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T21:55:07Z","timestamp":1694642107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1241962\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,13]]},"references-count":63,"alternative-id":["10.3389\/fendo.2023.1241962"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1241962","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,13]]},"article-number":"1241962"}}